Diagnosis of Dupuytren's disease typically involves feeling the palm areas to check for nodules and recording how many nodules are found. Your doctor will likely ask you to try to place your hands ...

The primary outcome was nodule hardness measured at 12 months, and patients were followed up for a total of 18 months. Injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules is ...

A drug already on the market for 20 years effectively reduced nodules associated with Dupuytren's disease in a mid-stage trial, researchers said. Patients receiving intranodular injections of ...

In Dupuytren's disease, connective tissue in the palm of the hands thickens. This causes nodules (small, hard lumps) to form under the skin of the palm. Over time, the nodules can form cords of tissue ...

Small blood vessels associated with proliferative cells in Dupuytren contracture nodules have an important role in the pathogenesis of the disease, according to a study published in Arthritis ...

Researchers found that an injection of the anti- Tumour Necrosis Factor (TNF) drug adalimumab into Dupuytren’s disease nodules results in reduction of the cell characteristics responsible for ...

Injection of the anti-TNF drug adalimumab into Dupuytren's disease nodules is effective in reducing nodule hardness and nodule size. Researchers at the Kennedy Institute, University of Oxford ...